RSS feed

Publications by Stine Lyngvi Fougner

23 publications found

Original articles

Sujan MAJ, Skarstad HMS, Rosvold G, Fougner SL, Nyrnes SA, Iversen AC, Follestad T, Salvesen KÅ, Moholdt T (2023)
Randomised controlled trial of preconception lifestyle intervention on maternal and offspring health in people with increased risk of gestational diabetes: study protocol for the BEFORE THE BEGINNING trial
BMJ Open, 13 (10), e073572
DOI 10.1136/bmjopen-2023-073572, PubMed 37793933

Lundstam K, Pretorius M, Bollerslev J, Godang K, Fagerland MW, Mollerup C, Fougner SL, Pernow Y, Aas T, Hessman O, Rosén T, Nordenström J, Jansson S, Hellström M, Heck A (2023)
Positive Effect of Parathyroidectomy Compared to Observation on BMD in a Randomized Controlled Trial of Mild Primary Hyperparathyroidism
J Bone Miner Res, 38 (3), 372-380
DOI 10.1002/jbmr.4763, PubMed 36593641

Pretorius M, Lundstam K, Heck A, Fagerland MW, Godang K, Mollerup C, Fougner SL, Pernow Y, Aas T, Hessman O, Rosén T, Nordenström J, Jansson S, Hellström M, Bollerslev J (2022)
Mortality and Morbidity in Mild Primary Hyperparathyroidism: Results From a 10-Year Prospective Randomized Controlled Trial of Parathyroidectomy Versus Observation
Ann Intern Med, 175 (6), 812-819
DOI 10.7326/M21-4416, PubMed 35436153

Fougner SL, Vanky E, Løvvik TS, Carlsen SM (2021)
No impact of gestational diabetes mellitus on pregnancy complications in women with PCOS, regardless of GDM criteria used
PLoS One, 16 (7), e0254895
DOI 10.1371/journal.pone.0254895, PubMed 34297751

Pretorius M, Lundstam K, Hellström M, Fagerland MW, Godang K, Mollerup C, Fougner SL, Pernow Y, Aas T, Hessman O, Rosén T, Nordenström J, Jansson S, Heck A, Bollerslev J (2020)
Effects of Parathyroidectomy on Quality of Life: 10 Years of Data From a Prospective Randomized Controlled Trial on Primary Hyperparathyroidism (the SIPH-Study)
J Bone Miner Res, 36 (1), 3-11
DOI 10.1002/jbmr.4199, PubMed 33125769

Gravdahl GB, Tronvik EA, Fougner SL, Solheim O (2016)
Pituitary Adenoma and Non-acute Headache: Is There an Association, and Does Treatment Help?
World Neurosurg, 92, 284-291
DOI 10.1016/j.wneu.2016.04.071, PubMed 27132176

Helseth R, Carlsen SM, Bollerslev J, Svartberg J, Øksnes M, Skeie S, Fougner SL (2015)
Preoperative octreotide therapy and surgery in acromegaly: associations between glucose homeostasis and treatment response
Endocrine, 51 (2), 298-307
DOI 10.1007/s12020-015-0679-6, PubMed 26179177

Fougner SL, Bollerslev J, Svartberg J, Øksnes M, Cooper J, Carlsen SM (2014)
Preoperative octreotide treatment of acromegaly: long-term results of a randomised controlled trial
Eur J Endocrinol, 171 (2), 229-35
DOI 10.1530/EJE-14-0249, PubMed 24866574

Heck A, Ringstad G, Fougner SL, Casar-Borota O, Nome T, Ramm-Pettersen J, Bollerslev J (2012)
Intensity of pituitary adenoma on T2-weighted magnetic resonance imaging predicts the response to octreotide treatment in newly diagnosed acromegaly
Clin Endocrinol (Oxf), 77 (1), 72-8
DOI 10.1111/j.1365-2265.2011.04286.x, PubMed 22066905

Lekva T, Berg JP, Fougner SL, Olstad OK, Ueland T, Bollerslev J (2012)
Gene expression profiling identifies ESRP1 as a potential regulator of epithelial mesenchymal transition in somatotroph adenomas from a large cohort of patients with acromegaly
J Clin Endocrinol Metab, 97 (8), E1506-14
DOI 10.1210/jc.2012-1760, PubMed 22585092

Casar-Borota O, Fougner SL, Bollerslev J, Nesland JM (2012)
KIT protein expression and mutational status of KIT gene in pituitary adenomas
Virchows Arch, 460 (2), 171-81
DOI 10.1007/s00428-011-1185-8, PubMed 22213031

Fougner SL, Casar-Borota O, Heck A, Berg JP, Bollerslev J (2012)
Adenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patients with acromegaly
Clin Endocrinol (Oxf), 76 (1), 96-102
DOI 10.1111/j.1365-2265.2011.04163.x, PubMed 21722151

Carlsen SM, Svartberg J, Schreiner T, Aanderud S, Johannesen O, Skeie S, Lund-Johansen M, Fougner SL, Bollerslev J, POTA study group (2011)
Six-month preoperative octreotide treatment in unselected, de novo patients with acromegaly: effect on biochemistry, tumour volume, and postoperative cure
Clin Endocrinol (Oxf), 74 (6), 736-43
DOI 10.1111/j.1365-2265.2011.03982.x, PubMed 21521254

Fougner SL, Lekva T, Borota OC, Hald JK, Bollerslev J, Berg JP (2010)
The expression of E-cadherin in somatotroph pituitary adenomas is related to tumor size, invasiveness, and somatostatin analog response
J Clin Endocrinol Metab, 95 (5), 2334-42
DOI 10.1210/jc.2009-2197, PubMed 20335450

Ueland T, Fougner SL, Godang K, Lekva T, Schurgers LJ, Scholz H, Halvorsen B, Schreiner T, Aukrust PL, Bollerslev J (2009)
Associations between Body Composition, Circulating Interleukin-1 Receptor Antagonist, Osteocalcin, and Insulin Metabolism in Active Acromegaly
Endocr Rev, 30 (7), 927
DOI 10.1210/edrv.30.7.9997, PubMed 28199500

Ueland T, Fougner SL, Godang K, Lekva T, Schurgers LJ, Scholz H, Halvorsen B, Schreiner T, Aukrust P, Bollerslev J (2009)
Associations between body composition, circulating interleukin-1 receptor antagonist, osteocalcin, and insulin metabolism in active acromegaly
J Clin Endocrinol Metab, 95 (1), 361-8
DOI 10.1210/jc.2009-0422, PubMed 19880791

Borota OC, Scheithauer BW, Fougner SL, Hald JK, Ramm-Pettersen J, Bollerslev J (2009)
Spindle cell oncocytoma of the adenohypophysis: report of a case with marked cellular atypia and recurrence despite adjuvant treatment
Clin Neuropathol, 28 (2), 91-5
DOI 10.5414/npp28091, PubMed 19353839

Carlsen SM, Lund-Johansen M, Schreiner T, Aanderud S, Johannesen O, Svartberg J, Cooper JG, Hald JK, Fougner SL, Bollerslev J, Preoperative Octreotide Treatment of Acromegaly study group (2008)
Preoperative octreotide treatment in newly diagnosed acromegalic patients with macroadenomas increases cure short-term postoperative rates: a prospective, randomized trial
J Clin Endocrinol Metab, 93 (8), 2984-90
DOI 10.1210/jc.2008-0315, PubMed 18492760

Fougner SL, Bollerslev J, Latif F, Hald JK, Lund T, Ramm-Pettersen J, Berg JP (2008)
Low levels of raf kinase inhibitory protein in growth hormone-secreting pituitary adenomas correlate with poor response to octreotide treatment
J Clin Endocrinol Metab, 93 (4), 1211-6
DOI 10.1210/jc.2007-2272, PubMed 18230656

Fougner SL, Borota OC, Berg JP, Hald JK, Ramm-Pettersen J, Bollerslev J (2007)
The clinical response to somatostatin analogues in acromegaly correlates to the somatostatin receptor subtype 2a protein expression of the adenoma
Clin Endocrinol (Oxf), 68 (3), 458-65
DOI 10.1111/j.1365-2265.2007.03065.x, PubMed 17941904

Ueland T, Fougner SL, Godang K, Schreiner T, Bollerslev J (2006)
Serum GH and IGF-I are significant determinants of bone turnover but not bone mineral density in active acromegaly: a prospective study of more than 70 consecutive patients
Eur J Endocrinol, 155 (5), 709-15
DOI 10.1530/eje.1.02285, PubMed 17062887

Review articles

Bollerslev J, Fougner SL, Berg JP (2009)
New directions in pharmacological treatment of acromegaly
Expert Opin Investig Drugs, 18 (1), 13-22
DOI 10.1517/13543780802554357, PubMed 19053878

Theses

Fougner SL (2010)
Molecular biological examination of somatotroph pituitaryadenomas related to clinical data from patients with acromegaly
In Series of dissertations submitted to the Faculty of Medicine, University of Oslo, Unipub, Oslo, no. 953, 1 b. (flere pag.)
BIBSYS 101286996, ISBN 978-82-8072-498-4